Customer Segmentation

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

An early-stage venture firm requested a high-level commercial due diligence of a potential investment